Trends in Healthcare Costs for Inflammatory Bowel Disease in South Korea

참고문헌 (10)

1. 이승훈, "Immunological pathogenesis of inflammatory bowel disease", Intestinal research, 16(1), pp.26~42 (2018), 대한장연구학회
2. Wee Khoon Ng, "Changing epidemiological trends of inflammatory bowel disease in Asia", Intestinal research, 14(2), pp.111~119 (2016), 대한장연구학회
3. Jung YS, "Incidence and clinical outcomes of inflammatory bowel disease in South Korea, 2011-2014 : a nationwide population-based study", Dig Dis Sci, 62, pp.2102~2112 (2017)
4. Hsu-Heng Yen, "Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide population-based study", Intestinal research, 17(1), pp.54~62 (2019), 대한장연구학회[DOI]
5. Jooyoung Lee, "Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study", Gut and Liver, 14(1), pp.89~99 (2020), 거트앤리버 소화기연관학회협의회
6. Kim JW, "Long-term evolution of direct healthcare costs for inflammatory bowel diseases : a population-based study(2006-2015)", Scand J Gastroenterol, 54, pp.419~426 (2019)
7. Jong Pil Im, "Changing treatment paradigms for the management of inflammatory bowel disease", The Korean Journal of Internal Medicine, 33(1), pp.28~35 (2018), 대한내과학회[DOI]
8. Choon Jin Ooi, "Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia", Intestinal research, 17(3), pp.285~310 (2019), 대한장연구학회[DOI]
9. Soo-Young Na, "Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease", Gut and Liver, 13(6), pp.604~616 (2019), 거트앤리버 소화기연관학회협의회[DOI]
10. Konstantinos H. Katsanos, "Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics", Gut and Liver, 11(4), pp.455~463 (2017), 거트앤리버 소화기연관학회협의회

관련 논문AI추천